Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A rare genetic mutation in the EGFR gene caused severe skin issues and other health problems in a Slovakian girl, who is now 4 years old and receiving care.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

EGFR inhibitors can cause yellowish skin eruptions.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Upadacitinib effectively treats psoriasis and lichen planus together.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Imuvert can prevent some chemotherapy-induced hair loss.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Cetuximab can cause unusual hair growth and hair loss.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.